Payment overview · 2025
General Payments
$226.29
2 reported records · 2 companies
Healthcare provider profile · identity verified
Daniel Junco, DO
Allopathic & Osteopathic Physicians|Family Medicine · BILLINGS, MT · NPI 1043711864
Verified facts
What the public records show
CMS Open Payments records show Daniel Junco, DO received $226.29 in general payments during 2025 across 2 reported records.
Exact Sciences Corporation accounted for 55.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $125.00 | 55.2% | 1 | 2025 |
| Madrigal Pharmaceuticals | Unresolved — no canonical attribution shown | $101.29 | 44.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $226.29 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| REZDIFFRA Normalized: rezdiffra |
Drug | Madrigal Pharmaceuticals | $101.29 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 693 | 199 |
| Levothyroxine Sodium | Levothyroxine Sodium | 625 | 138 |
| Amlodipine Besylate | Amlodipine Besylate | 416 | 126 |
| Gabapentin | Gabapentin | 363 | 87 |
| Lisinopril | Lisinopril | 362 | 102 |
| Losartan Potassium | Losartan Potassium | 356 | 107 |
| Omeprazole | Omeprazole | 275 | 79 |
| Pantoprazole Sodium | Pantoprazole Sodium | 257 | 78 |
| Tamsulosin Hcl | Tamsulosin Hcl | 223 | 65 |
| Hydrochlorothiazide | Hydrochlorothiazide | 197 | 45 |
| Sertraline Hcl | Sertraline Hcl | 194 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 187 | 45 |
| Potassium Chloride | Potassium Chloride | 185 | 50 |
| Eliquis | Apixaban | 161 | 35 |
| Metformin Hcl | Metformin Hcl | 159 | 53 |
| Furosemide | Furosemide | 153 | 44 |
| Allopurinol | Allopurinol | 150 | 38 |
| Simvastatin | Simvastatin | 138 | 34 |
| Trazodone Hcl | Trazodone Hcl | 133 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 129 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 128 | 36 |
| Donepezil Hcl | Donepezil Hcl | 124 | 19 |
| Meloxicam | Meloxicam | 120 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 115 | 47 |
| Ozempic | Semaglutide | 109 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 101 | 46 |
| Metformin Hcl Er | Metformin Hcl | 98 | 35 |
| Carvedilol | Carvedilol | 92 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 92 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 92 | 21 |
| Memantine Hcl | Memantine Hcl | 91 | 13 |
| Buspirone Hcl | Buspirone Hcl | 90 | 20 |
| Mirtazapine | Mirtazapine | 89 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 85 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 85 | 29 |
| Spironolactone | Spironolactone | 83 | 22 |
| Tramadol Hcl | Tramadol Hcl | 83 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 80 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 76 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 74 | 13 |
| Levetiracetam | Levetiracetam | 74 | 11 |
| Metoprolol Tartrate | Metoprolol Tartrate | 71 | 20 |
| Warfarin Sodium | Warfarin Sodium | 68 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 65 | 25 |
| Januvia | Sitagliptin Phosphate | 62 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 62 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 60 | 20 |
| Aripiprazole | Aripiprazole | 59 | suppressed |
| Finasteride | Finasteride | 59 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 58 | 21 |
| Prednisone | Prednisone | 58 | 12 |
| Olanzapine | Olanzapine | 56 | suppressed |
| Bupropion Xl | Bupropion Hcl | 54 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 49 | 23 |
| Amitriptyline Hcl | Amitriptyline Hcl | 47 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 47 | 13 |
| Divalproex Sodium | Divalproex Sodium | 43 | suppressed |
| Baclofen | Baclofen | 42 | suppressed |
| Jardiance | Empagliflozin | 41 | 11 |
| Spiriva Respimat | Tiotropium Bromide | 41 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 18 |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 39 | 11 |
| Methocarbamol | Methocarbamol | 39 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 38 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Lorazepam | Lorazepam | 35 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 35 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 34 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | 11 |
| Torsemide | Torsemide | 34 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 34 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 33 | 12 |
| Lamotrigine | Lamotrigine | 32 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 32 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 32 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 31 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 31 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 31 | suppressed |
| Cephalexin | Cephalexin | 30 | 16 |
| Famotidine | Famotidine | 30 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | 12 |
| Celecoxib | Celecoxib | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Nifedipine Er | Nifedipine | 28 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 27 | suppressed |
| Lovastatin | Lovastatin | 27 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 26 | suppressed |
| Mounjaro | Tirzepatide | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | suppressed |
| Ketoconazole | Ketoconazole | 24 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 23 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 23 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Latanoprost | Latanoprost | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 11 |
| Ezetimibe | Ezetimibe | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | 11 |
| Enoxaparin Sodium | Enoxaparin Sodium | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Ursodiol | Ursodiol | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Azithromycin | Azithromycin | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $226.29 · 2 records | Exact Sciences Corporation | REZDIFFRA, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error